MENU

About infertility

BLOG

2026-06-16

Breaking the Myths of IVF Sex Selection: Unveiling 4 Key Techniques

With rapid advancements in medical technology, in vitro fertilization (IVF) has become a beacon of hope for many couples struggling with infertility. However, since IVF involves fertilization outside the body, many naturally wonder: Can we choose the sex of our future baby? This article explores this question from both legal and technical perspectives, clarifying common misconceptions surrounding sex selection in IVF.

 

Can You Choose the Sex of an IVF Baby? Is Sex Selection Legal? 

Is it possible to freely choose the sex of an IVF baby? According to Article 16,Paragraph 3 of the Assisted Reproduction Act in Taiwan, sex selection of embryos is strictly prohibited during assisted reproductive procedures. Therefore, any hospital or fertility center claiming to offer IVF sex selection services is violating the law.

The only exception is if either partner carries a sex-linked genetic condition, such as hemophilia, color blindness, or spinal muscular atrophy (SMA). In such cases, preimplantation genetic testing (PGT) may be used to identify the sex of the embryo. This is done solely to prevent the condition from being inherited and to increase the chances of selecting a healthy embryo unaffected by the disease.

 

An IVF Technology Overview: From 1.0 to 3.5, Your Go-To Guide

In vitro fertilization (IVF) is a procedure that involves retrieving eggs and sperm, fertilizing them in the laboratory, and then culturing the resulting embryos before transferring them into the uterus for continued development. IVF is currently the most effective clinical treatment for infertility.

IVF technology has evolved significantly, from the first-generation traditional IVF (1.0) to the latest Generation 3.5 featuring AI-assisted embryo selection. Each generation is designed to address specific patient needs and clinical indications. Below is a detailed introduction to the four main generations of IVF technology available today.

First-Generation IVF: Conventional In Vitro Fertilization

First-generation IVF involves retrieving a certain number of high-quality sperm and eggs and placing them together in a culture dish for incubation. Fertilization occurs naturally within the culture medium, allowing the sperm to penetrate the egg without additional assistance. This traditional method represents the foundational technique of in vitro fertilization.

 

Second-Generation IVF: Intracytoplasmic Sperm Injection (ICSI)

Second-generation IVF, known as Intracytoplasmic Sperm Injection (ICSI), is employed in cases of low sperm count or poor motility. Under a high-powered microscope, a single sperm with optimal motility and morphology is carefully selected and directly injected into the cytoplasm of the egg. This highly precise technique enhances the chances of fertilization, particularly when natural sperm-egg interaction is unlikely to occur.

 

Third-Generation IVF: Preimplantation Genetic Testing for Aneuploidy (PGT-A) / Preimplantation Genetic Screening (PGS) 

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a screening technique used to detect chromosomal abnormalities in embryos prior to implantation, thereby avoiding the transfer of abnormal embryos. Its primary purpose is to identify high-quality embryos and ensure a normal chromosome count, which ultimately increases the successful implantation rate and reduces the risk of miscarriage.

 

PGT-A involves a biopsy of the trophectoderm—the outer layer of the blastocyst—typically performed on days 5 to 7 of embryo development. A small sample of cells is carefully collected for genetic analysis, without harming the inner cell mass, which eventually develops into the fetus.

By screening out aneuploid embryos, PGT-A helps in the selection of embryos with the highest developmental potential. This testing is particularly recommended for:

  • Women aged 35 and older

  • Couples with a history of recurrent miscarriages

  • Individuals who have experienced multiple unsuccessful IVF treatments

  • Couples with a known family history of genetic or chromosomal disorders

Please remember to consult a medical professional to determine whether PGT-A is appropriate for your individual situation!

 

It is also important to note that PGT-A is not a cure-all and does not guarantee a 100% successful pregnancy. For an embryo to develop successfully and result in a healthy baby, gene expression must occur precisely and in the correct sequence throughout each dynamic stage of development. Even with chromosomally normal embryos, other biological factors can influence implantation and pregnancy outcomes.

 

Generation 3.5 IVF: Real-Time Embryo Monitoring with Time-Lapse Imaging and KID Score AI-Based Embryo Selection

The time-lapse embryo monitoring system is a state-of-the-art incubator equipped with an integrated microscope and camera that captures images of developing embryos every 10 minutes. These images are compiled into a continuous time-lapse video, allowing embryologists to observe and document the entire process of embryonic cell division and development in real time.

Unlike traditional incubators, time-lapse systems enable continuous monitoring without the need to remove culture dishes from the incubator, thereby minimizing physical disturbances. This helps maintain a stable environment by reducing fluctuations in key factors such as temperature, humidity, gas concentration, and pH levels—creating optimal conditions for embryo development, much like growing in a private, undisturbed suite.

Beyond real-time observation, the system leverages AI and big data analytics, including tools like the KID Score, to assess and rank embryos based on their developmental dynamics. This technique enhances the selection of high-quality embryos with stronger implantation potential, ultimately increasing the chances of a successful pregnancy.

 

our Journey to Parenthood Starts Here: IVF Services at TFC Taipei Fertility Center

Led by Dr. Chii-Ruey Tzeng, well known as the "Father of IVF in Taiwan," TFC Taipei Fertility Center features an expert team with an average of over 20 years in reproductive clinical practice and a phenomenal IVF success rate of nearly 70%. TFC is currently the only reproductive center in Taiwan awarded the SNQ (Symbol of National Quality), reinforcing its exceptional standards of care.

TFC offers a state-of-the-art IVF and embryology laboratory, built to international specifications. As one of the few positive-pressure labs in Taiwan, it ensures optimal air quality and contamination control. The lab is equipped with three high-end time-lapse incubators, each valued in the millions of NTD, allowing for continuous, detailed monitoring of embryo development. TFC embryologists are highly trained and experienced, adept at providing accurate embryo assessments and timely updates to the medical team for informed clinical decision-making.

Located in a premium office building in Taipei's CBD, TFC combines advanced medical infrastructure with exceptional accessibility. Despite its high-end facilities, treatment costs remain comparable to those of other fertility centers and even teaching hospitals. Patients benefit from a one-stop, streamlined care experience in a serene and thoughtfully designed environment. Thoughtful amenities—such as light refreshments, post-procedure meals, blankets, and device charging stations—further ensure comfort and peace of mind.

At TFC, you're not only pursuing pregnancy—you're receiving comprehensive care for your body, mind, and spirit.

 

醫療新知類別: # in-vitro-fertilization